SB 668 Requires health benefit plans to establish equal out of pocket costs for covered oral and intravenously administered chemotherapy medications
Sponsor: Silvey
LR Number: 5155S.02T Fiscal Note available
Committee: Small Business, Insurance and Industry
Last Action: 3/19/2014 - Signed by Governor Journal Page: S581
Title: SS SB 668 Calendar Position:
Effective Date: August 28, 2014
House Handler: Solon

Full Bill Text | All Actions | Amendments/CCRs/CCSs | Available Summaries | Senate Home Page | List of 2014 Senate Bills

Current Bill Summary

SS/SB 668 - This act requires that insurers that offer benefits for cancer treatment offer oral anticancer medication at terms at least as favorable as intravenously administered anticancer medications. Health benefit plans can be in compliance with this section if orally prescribed anticancer medications are offered at a rate that limits total out-of-pocket costs to seventy-five dollars for a thirty day period, and high deductible plans can meet these compliance terms after the satisfaction of the annual deductible.

This act is similar to SB 663 (2014).